Shanghai Kehua Bio-engineering Co Ltd (KHB) develops, manufactures and markets in vitro diagnostic devices and related regents and kits. It is one of the global suppliers of IVD products to WHO, UNICEF, HIV/AIDS Initiative. The company provides, various immunologic, biochemical, molecular diagnostic reagents and laboratory instruments; POCT (Colloidal gold) products and other products for diagnosis. The company also provides comprehensive services in regional medical testing centers.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company’s R&D focuses on technology platforms to develop clinical IVD reagents and fully automatic analyzers. It focuses on promoting the serial development and integration of reagents and instruments. The company’s major focusing areas also include developing immune diagnosis, biochemical diagnosis, molecular diagnosis and POCT (point-of-care testing). The company presently boasts a portfolio of over 100 ongoing research projects. It has obtained 260 CFDA (China Food and Drug Administration) registration certificates and holds a remarkable count of over 50 invention patents. The company’s R&D centers and production bases are in Italy, Shenzhen, Xi’an, and Suzhou.